ÚÀѽ£¬ÄãÖªµÀ²»£¬ÎÒ×î½üÓÖÈ¥ÁËÒ»ÌËÇíɽСÏï×Ó£¡¿É´ø¾¢ÁË£¬¸úÄãßëßë°¡£¬ÕâµØ·½ËµÊǸöСÏï×Ó£¬Êµ¼ÊÉϿɲ»ÊÇÄÇô¼òµ¥¡£ÄãÒªÕæÇÆ²»ÆðËü°É£¬×¼¿÷Ëð£¡
ÇíɽСÏï×Ó£¬ÀϹþ¶û±õÈ˶¼¶®µÄ±¦µØ
Õâ¸ö°É£¬ÇíɽСÏï×Ó°¡£¬¶«±±È˶¼ÖªµÀËü£¬¿ÉÄãÒªÕæÎÊÆðÀ´£¬Ôõô¸öÖªµÀ·¨¶ù£¿ºÙ£¬Ê®Óа˾ÅÄܸøÕûÃÔºýÁË¡£Ëü¾ÍÔÚ¹þ¶û±õÀϵÀÍâÄÇÆ¬¶ù£¬¸úÀϽÖÅþÁÚ£¬Ïï×Ó²»¿í£¬ÃÅÁ³Ò²²»ÆðÑÛ£¬Â¥ÉÏ¥ϵÄÎÝ×Ó°É£¬¾ÉµÃ¸úÀÏÓ°Ï·ÀïÍ·µÄ³¡¾°ËƵġ£µ«ÎÒ¸úÄã½²°¡£¬ÀïÍ·µÄÃŵÀÔôÀ¶à£¬ÄãËæ±ãÁï´ïÁï´ï£¬ËµÎ´±Ø¾ÍÄÜÕû³ö¸ö¾ªÏ²À´¡£
ÎÒÍ·»ØÈ¥ÄÇ»á¶ù»¹Í¦ÄêÇᣬѰ˼¾ÍËæ±ã¿´¿´£¬½á¹û°¡£¬×ßµ½Ò»¸öºúͬ¿Ú£¬³ò¼ûÓиöÀÏÍ·¸éÄǶùÂôÌǺù«¡£Äã˵ÌǺù«Ëû³Ô¹ý°¡£¿¿ÉÎÒÒ»³¢£¬ÄÇζ¶ù£¬±ÈÒ»°ã½Ö±ß̯¶ùµÄ»¹ËíµÀ£¬ËáÌð±ÈÀýÄÃÄóµÃÀÏ×¼ÁË¡£ØÊºó²ÅÖªµÀ£¬Õâ¼ÒÌǺù«̯ÒѾ°ÚÁ˼¸Ê®Ä꣬ËÄÖܵÄÈ˶¼ÈÏËü¡£ÎÒ˵°É£¬ÇíɽСÏï×ÓÕâµØ·½£¬³ÔµÄÍæµÄ£¬¾Í¸ú²Ø×ŵÄС·ÏÎïËÆµÄ£¬ÄãµÃÂýÂýÕÒ£¬Ï¸Ï¸Æ·¡£
ÇíɽСÏï×ÓµÄÕýÈ··¿ª·½·¨
ÕÕÎÒ˵°¡£¬È¥ÇíɽСÏï×ÓÁï´ï£¬Ç§Íò±ð¹â±¼×ÅÄÇÐ©Íøºì´ò¿¨µØ¶ùÈ¥£¬ÄǾÍÀË·ÑÁË¡£Ò»°ãÇé¿öϰɣ¬Äã¾ÍµÃ³ò×¼ÄÇЩ²»ÆðÑÛµÄС̯¡¢Ð¡µê£¬ÉõÖÁÁ¬¸öÕÐÅÆ¶¼Ã»Óеĵط½£¬×¼ÓÐÃŵÀ£¡
ÇÄÃþ¸æËßÄã°¡£¬ÇíɽСÏï×ÓÀïÍ·ÓмÒÂô¹ø°üÈâµÄСµê£¬¿ÉÀÏËíµÀÁË£¡ËüÄǹø°üÈâ²»ÊÇÌð¿ÚµÄ£¬ÊÇËáÌð¿Ú£¬»¹´øµã¶ùËâÏ㣬¸ú¹þ¶û±õÍâµØÈ˼ÒÀïÍ·ÕûµÄһģһÑù¡£È¥µÄʱºò¼ÇµÃÔçµã¶ùÈ¥£¬ÍíÁ˾ÍûλÖÃÁË£¡
ÁíÓа¡£¬ÄÇÏï×ÓÀïµÄÀÏÊéµê£¬ËäÈ»µØ·½Ð¡£¬¿ÉÊéÔô¶à£¬É¶Êé¶¼ÓУ¬É¶Äê´úµÄ¶¼ÓС£ÎÒÉÏ»ØÈ¥·Ê飬¾ÓÈ»Õû³öÀ´Ò»±¾ÎÒÒ¯ÄêÇáʱ¿´µÄÀÏÔÓÖ¾£¬ÔôÓÐÒâ˼¡£Äã˵£¬ÕâµØ·½ÊDz»ÊǵÃϸϸ×ÁÄ¥£¿
ÇíɽСÏï×ÓµÄÀϹÊÊÂ
˵ÆðÀ´£¬ÕâÇíɽСÏï×ÓÁíÓеãÀúÊ·µÄÒâ˼¡£Ìý˵°¡£¬ÒÔǰÕâËÄÖÜÊÇÉ̼ÖÔÆ¼¯µÄµØ·½£¬ÄÏÀ´µÄ±±ÍùµÄ¶¼°®ÔÚÕâ¶ùÕûµãÂòÂô¡£ØÊºó°É£¬¾ÍÂýÂý³ÉÁËÏÖÔÚÕâÑù£¬³ÔµÄÍæµÄÔ½À´Ô½¶à£¬Ïï×ÓÒ²Ô½À´Ô½ÓÐζµÀ¡£ÄãÒªÊǸúÄǶùµÄÀÏÈËßëß룬»¹ÄÜÌýËûÃǽ²½²ÕâÀïµÄÀϹÊÊ£¬É¶ÔËÊä¶ÓµÄ£¬É¶ÀÏ»õÕ»µÄ£¬¿ÉÓÐÒâ˼ÁË£¡
ÎҼǵÃÓÐÒ»»Ø£¬ÎÒÈ¥Ïï×ÓÀïÍ·Áï´ï£¬ÅöÉÏÒ»¸öÀÏ´óÒ¯¸éÄǶùÂôÀÏÎï¼þ¶ù¡£ÎÒÒ»³ò£¬Ò»¶Ñͺø¡¢Ìú¹ÞɶµÄ£¬ÔôÓÐÄê´ú¸Ð¡£ÎÒ¾ÍÎÊËû£¬ÕâЩ¹¤¾ßÄĶùÀ´µÄѽ£¿´óÒ¯ÀÖÁË£¬ËµÊÇËûµùµ±Äê´Ó¶«±±µ½¹ØÍâ´ø»ØÀ´µÄ¡£ÎÒÐÄ˵£¬ÕâÏï×ÓÀïµÄ¹¤¾ß£¬¹ûÕæ·×Æç°ã°¡¡£
ÄÇÄã¿ÉÄÜÒªÎÊÁË£¬ÕâÇíɽСÏï×ÓÁíÓÐɶ½²¾¿°¡£¿ÎÒ¸úÄã½²£¬×îÖØÒªµÄÒ»µã¾ÍÊÇ£º±ð׿±£¬ÂýÂý¹ä£¬×Ðϸ¿´¡£Ã¿¼Òµê¡¢Ã¿¸ö̯£¬ÐËÐí¶¼ÓеãÃŵÀ¡£ÄãÒªÊǼ±¼±åáµØ×ßһȦ£¬ÄǾÍɶ¶¼Ã»Õû×Å¡£
ÕâôµØ°É£¬Ï´ÎÄãÈ¥µÄʱºò£¬¼ÇµÃ´øµãʱ¼ä£¬¶ö×ŶÇ×Ó£¬Ñ°Ãþ×ŵãºÃ³ÔµÄ£¡
±êÇ©£ºÇíɽСÏï×Ó¡¢ÀϵÀÍâ¡¢ËíµÀÃÀʳ¡¢¶«±±¹ÊÊ¡¢¹þ¶û±õ·çÇé
¡¶³É¶¼ÖкͿì²ÍСÏï×ÓÔÚÄÄÀï°¡¡·
Èç¹û°ÑÊÓÒ°·Åµ½½ñÌìµÄÊÀ½çÇé¿öÀÖйú¾¼ÃµÄÕâÖÖÑ¡Ôñ£¬ÆäʵԽ·¢ÇåÎú¡£
¡¶ÖØÇìºÏ´¨ÇøÂô±ÆµÄµØ·½¡·
Ò©ÈÚȦ¼à²âÏÔʾ£ºAvidity Biosciences, Inc.£¨¡°Avidity¡±£¬ÄÉ˹´ï¿Ë´úÂ룺RNA£©ÊÇÒ»¼ÒÉúÎïÖÆÒ©¹«Ë¾£¬ÖÂÁ¦ÓÚÍÆ³öÒ»ÀàÃûΪ¿¹Ìå¹ÑºËÜÕËáżÁªÎAntibody Oligonucleotide Conjugates£¬¡°AOCs?¡±£©µÄÐÂÐÍ RNA ÁÆ·¨£¬ÒÔÏÔÖø¸ÄÉÆ»¼ÕßÉúÃüÖÊÁ¿¡£Æä¶Ê»á´Ëǰȷ¶¨2026 Äê 2 Ô 12 ÈÕÃÀ¹ú¶«²¿Ê±¼äÊÕÅÌʱΪ¹ÉȨ¹ÒºÅÈÕ£¨Record Date£©£¬ÓÃÓÚÏò¸Ã¹ÒºÅÈÕ³ÖÓÐ Avidity ÆÕͨ¹ÉµÄ¹É¶«°´±ÈÀý·ÖÅÉ?Atrium Therapeutics, Inc.£¨¡°SpinCo¡±£©È«²¿ÒÑ¿¯ÐÐÁ÷ͨÆÕͨ¹É¡£
¡¶24СʱŮº¢×ÓÉÏÃÅЧÀÍ¡·
2015Ä꣬¹ú×ÊίÅú×¼ÖйúÎå¿ó¼¯ÍÅÓëÖÐÒ±¼¯ÍÅÕ½ÂÔÖØ×飬ּÔÚ´òÔìÈ«ÇòÁìÏȵĽðÊôÓë¿ó²úÆóÒµ¼¯ÍÅ¡£ÆäÖУ¬ÖÐÒ±¼¯ÍÅÆìÏÂÓµÓз¿µØ²úƽ̨ÖÐÒ±ÖÃÒµ£¬²¢ÓëÎå¿óµØ²úÐγÉͬҵ¾ºÕù¹ØÏµ¡£Òò´Ë£¬Á½ÕßµÄÕûºÏ±»ÈÏΪÊǾÖÊÆËùÇ÷¡£